That article pisses me off. They start out talking about the guy and say he's signed up for a D-4F trial. A drug being developed for Novartis.
Then it spends the next 90% of the article talking almost entirely about Pfizer's drug instead.
WTF?!?!
Clearly someone at Pfizer took someone at USAToday out to lunch and gave him a nice "gift." So messed up. The guy they did the story on isn't in a trial for Pfizer's drug, he's in a trial for Novartis' drug. I swear, Novartis rarely gets any of the credit it deserves.